Mandate

Vinge has advised Bilia in connection with the issuance and repurchase of bonds

Vinge has advised Bilia AB (publ) in connection with the issue of new senior and non subordinated bonds with a framework amount of SEK 1 500 000 000 as well as the repurchase of SEK 500 000 000 of a previously issued senior and non subordinated bond with a maturity date in 2021.

Initially, a bond in the amount of SEK 800 000 000 was issued, of which SEK 500 000 000 will be used for the repurchase of the previously issued bond and the remaining amount for repayment of bank loans as well as part financing of Bilia’s acquisitions in Belgium. 

The newly issued bonds have a term of 5 years and are subject to a variable interest of STIBOR 3M + 1.40%. 

Vinge’s team primarily consisted of Anders Strid, Lina André and Henrik Wastenson (tax).
 

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026